<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02465255</url>
  </required_header>
  <id_info>
    <org_study_id>RC 22/13</org_study_id>
    <nct_id>NCT02465255</nct_id>
  </id_info>
  <brief_title>Sublingual Analgesia for Acute Abdominal Pain in Children</brief_title>
  <official_title>Sublingual Analgesia for Acute Abdominal Pain in Children. Ketorolac Versus Tramadol Versus Paracetamol, a Randomized, Control Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IRCCS Burlo Garofolo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IRCCS Burlo Garofolo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acute abdominal pain is a frequent symptom in children admitted to the emergency department .
      In the past the fear of masking a surgical condition has justified withholding analgesia in
      patients with acute abdominal pain. By the 2000s, some clinical trials established that
      opioid analgesia before surgical consultation does not affect diagnostic accuracy or outcome
      in children with acute abdominal pain. Despite this, acute abdominal pain is still
      undertreated in this setting. Published paediatric trials studied the effect of opioid
      analgesia administered by parenteral route or by mouth. To the best of our knowledge no study
      investigated the effectiveness of sublingual analgesia.

      The purpose of this randomized controlled trial is to assess the effectiveness of three
      different drugs (ketorolac, tramadol, paracetamol), administered by the sublingual route, in
      children complaining of acute abdominal pain.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 2015</start_date>
  <completion_date type="Actual">June 2017</completion_date>
  <primary_completion_date type="Actual">June 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain Score</measure>
    <time_frame>120 minutes after drug administration</time_frame>
    <description>Pain score evaluated with visual analogical scale (VAS) or Numeric Rating Scale (NRS) depending on child age</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain Score</measure>
    <time_frame>30 minutes after drug administration</time_frame>
    <description>Pain score evaluated with visual analogical scale (VAS) or Numeric Rating Scale (NRS) depending on child age</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Score</measure>
    <time_frame>60 minutes after drug administration</time_frame>
    <description>Pain score evaluated with visual analogical scale (VAS) or Numeric Rating Scale (NRS) depending on child age</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Missed or delayed diagnosis of acute appendicitis or other abdominal pathology (i.e., pancreatitis)</measure>
    <time_frame>24 hours after drug administration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Missed or delayed diagnosis of acute appendicitis or other abdominal pathology (i.e., pancreatitis)</measure>
    <time_frame>48 hours after drug administration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>up to 180 hours after the drug administration</time_frame>
    <description>Presence of nausea, vomiting, diarrhea, headache, hyper- or hypotension, decreased excretion of urine, bleeding</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">210</enrollment>
  <condition>Abdominal Pain</condition>
  <arm_group>
    <arm_group_label>Ketorolac</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ketorolac 0.5 mg/kg administrated by sublingual route</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tramadol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Tramadol 2.0 mg/kg administrated by sublingual route</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Acetaminophen (paracetamol)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Acetaminophen (paracetamol) 20.0 mg/kg administrated by sublingual route</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketorolac</intervention_name>
    <arm_group_label>Ketorolac</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tramadol</intervention_name>
    <arm_group_label>Tramadol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetaminophen</intervention_name>
    <arm_group_label>Acetaminophen (paracetamol)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 4 to 18 years

          -  Emergency department admission for moderate to severe acute abdominal pain (VAS/NRS
             score &gt;=6)

          -  Informed consent signed by parents or legal guardians

        Exclusion Criteria:

          -  Known allergy or sensitivity to nonsteroidal anti-inflammatory drug, opioids or
             acetaminophen

          -  Use of analgesic drugs in the 8 hours before

          -  Clinical suspicion of abdominal pain due to fecal stasis

          -  Moderate or severe dehydration (weight loss of more than 5%)

          -  Known nephropathy, liver disease, metabolic or neurologic disease

          -  Thrombocytopenia or history of bleeding disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Egidio Barbi, MD</last_name>
    <role>Study Chair</role>
    <affiliation>IRCCS Burlo Garofolo, Trieste, Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Elena Neri, MD</last_name>
    <role>Study Director</role>
    <affiliation>IRCCS Burlo Garofolo, Trieste, Italy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Giorgio Cozzi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>IRCCS Burlo Garofolo, Trieste, Italy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>IRCCS Burlo Garofolo</name>
      <address>
        <city>Trieste</city>
        <state>Friuli Venezia Giulia</state>
        <zip>34137</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 3, 2015</study_first_submitted>
  <study_first_submitted_qc>June 4, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 8, 2015</study_first_posted>
  <last_update_submitted>August 17, 2017</last_update_submitted>
  <last_update_submitted_qc>August 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>IRCCS Burlo Garofolo</investigator_affiliation>
    <investigator_full_name>Luca Ronfani</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Acute Abdominal Pain</keyword>
  <keyword>Sublingual Analgesia</keyword>
  <keyword>Children</keyword>
  <keyword>Ketorolac</keyword>
  <keyword>Tramadol</keyword>
  <keyword>Paracetamol</keyword>
  <keyword>Analgesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Abdominal Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Ketorolac</mesh_term>
    <mesh_term>Ketorolac Tromethamine</mesh_term>
    <mesh_term>Tramadol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

